Role of Brodalumab in the Modulation of Gut Microbiome in Psoriatic Patients
Clinical trial NCT04680624 · UNKNOWN
Trial details
- NCT number
- NCT04680624
- Sponsor
- Association pour la Recherche Clinique et Immunologique
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2022-01-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.